JAMA study: editorials play role in branded vs generic debate
This article was originally published in Scrip
Executive Summary
There is "no evidence of superiority" for brand-name cardiovascular drugs over their generic counterparts, a meta-analysis conducted by Harvard researchers using sources from the last 25 years has concluded.